VANIQA crème tb 60 g

7680556580022 CH-55658 D11AX16 10.99.0.
VANIQA crème tb 60 g
VANIQA crème tb 60 g
VANIQA crème tb 60 g
1 / 3
google

Details

Product number
5565801
CPT
-
Packaging group
60
Unit
g
Composition
eflornithinum 115 mg ut eflornithini hydrochloridum monohydricum, aqua purificata, glyceroli stearas, macrogoli 100 stearas, alcohol cetylicus et stearylicus 26 mg, macrogoli aether cetostearylicus, paraffinum perliquidum, alcohol stearylicus 14.2 mg, dimeticonum, natrii hydroxidum, phenoxyethanolum, propylis parahydroxybenzoas 0.32 mg, E 218 0.8 mg, ad unguentum pro 1 g.

Articles (1)

Vaniqa, Crème
Crème
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/02/2022
Patient information leaflet
Français
24/02/2022
Patient information leaflet
Italien
24/02/2022
Professional SmPC
Allemand
24/02/2022
Professional SmPC
Français
24/02/2022
Professional SmPC
Italien
24/02/2022

Detailed composition

Substance Quantity Type Category
(N/A)
115.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
26.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
14.2 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
0.32 MG Substance HBESI
(N/A)
0.8 MG Substance HBESI

Authorization holder

Almirall AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
55658
Drug name
Vaniqa, Crème
Galenic form
CREM
ATC Code
D11AX16
Authorization status
Z
Dispensation category
B
First authorization
15/04/2003
Authorization expiration date
31/12/9999
IT number
10.99.0.
Domain
Human medicine
Field of application
Hirsutismus im Gesicht bei Frauen

Packaging details

Description (FR)
VANIQA crème tb 60 g
Description (DE)
VANIQA Creme Tb 60 g
Market launch
15/04/2003
Narcotic (BTM)
No

Other packaging sizes